Table 1 Clinical and demographic characteristics of breast cancer patients treated with FEC/TX (n=66) and FEC/TX plus H (n=25)
Characteristic | 66 patients treated with FEC/TX | 25 patients treated with FEC/TX plus H | ||
|---|---|---|---|---|
| Â | pCR No. cases (%) | RD No. cases (%) | pCR No. cases (%) | RD No. cases (%) |
All patients | 25 (100) | 41 (100) | 12(100) | 13 (100) |
Age in yrs | ||||
Median (range) | 49 (34-69) | 49 (26- 67) | 50 (37-59) | 49 (39-64) |
Histology | ||||
Invasive ductal (IDC) | 24 (96.0) | 38 (92.7) | 12 (100.0) | 12 (92.3) |
Invasive lobular (ILC) | 0 (0.0) | 1 (2.4) | 0 (0.0) | 0 (0.0) |
Invasive mucinous (IMC) | 0(0.0) | 1 (2.4) | 0(0.0) | 0 (0.0) |
NOS | 1 (4.0) | 1 (2.4) | 0 (0.0) | 1 (7.7) |
Clinical tumor size at baseline | ||||
T1 | 0 (0) | 1 (2.4) | 0 (0.0) | 0 (0.0) |
T2 | 9 (36.0) | 14 (34.1) | 4 (33.3) | 7 (53.8) |
T3 | 14 (56.0) | 23 (56.1) | 6 (50.0) | 4 (30.8) |
T4 | 2 (8.0) | 3 (7.3) | 2 (16.7) | 2(15.4) |
Clinical node status at baseline | ||||
N0 | 8 (32.0) | 15 (36.6) | 2 (16.7) | 4 (30.8) |
N1 | 12 (48.0) | 22 (53.7) | 7(58.3) | 4 (30.8) |
N2 | 2 (8.0) | 2 (4.9) | 1 (8.3) | 4 (30.8) |
N3 | 3 (12.0) | 1 (2.4) | 1 (8.3) | 0 (0.0) |
Unkown | Â | Â | 1 (8.3) | 1 (7.7) |
Histologic Grade | ||||
1 & 2 | 4 (16.0) | 10 (24.4) | 6 (50.0) | 3 (23.1) |
3 | 14 (56.0) | 26 (63.4) | 4 (33.3) | 9 (69.2) |
Unknown | 7 (28.0) | 5 (12.2) | 2 (16.7) | 1 (7.7) |
ER status | ||||
Positive1 | 8 (32.0) | 20 (48.8) | 2 (1.7) | 8 (61.5) |
Negative | 17 (68.0) | 20 (48.8) | 10 (76.9) | 5 (38.5) |
Unknown | 0 (0.0) | 1 (2.4) | Â | Â |
HER-2 status | ||||
Positive 2 | 5 (20.0) | 5 (12.2) | 13 (100) | 12 (92.3) |
Negative | 20 (80.0) | 33 (80.5) | 0 (0.0) | 1 (7.7) |
Unknown | 0 (0.0) | 3 (7.3) | 0 (0.0) | 0 (0.0) |